Long-Term Survival Outcomes in Belatacept-Treated vs. Cyclosporine-Treated Patients: Final Results From BENEFIT-EXT

被引：0
|
作者：
Florman, S. [1 ]
Bray, R. [2 ]
Gebel, H. [2 ]
Kuypers, D. [3 ]
Larsen, C. [2 ]
Medina Pestana, J. [4 ]
Rial, M. [5 ]
Rostaing, L. [6 ]
Wekerle, T. [7 ]
Grannas, G. [8 ]
Meier-Kriesche, U. [9 ]
Polinsky, M. [9 ]
Townsend, R. [9 ]
Munier, S. [9 ]
Grinyo, J. [10 ]
Durrbach, A. [11 ]
机构：
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
[2] Emory Univ, Atlanta, GA 30322 USA
[3] Univ Hosp Leuven, Leuven, Belgium
[4] Hosp Rim, Sao Paulo, Brazil
[5] Inst Nefrol, Buenos Aires, DF, Argentina
[6] Univ Hosp, Toulouse, France
[7] Med Univ Vienna, Vienna, Austria
[8] Hannover Med Sch, D-30623 Hannover, Germany
[9] Bristol Myers Squibb, Lawrenceville, NJ USA
[10] Univ Hosp Bellvitge, Barcelona, Spain
[11] Univ Hop Bicetre, Villejuif, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P-45
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [41] PRIMARY OUTCOMES FROM A RANDOMIZED, PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN ECD KIDNEY TRANSPLANTS (BENEFIT-EXT STUDY)
    Durrbach, A.
    Larsen, C.
    Medina-Pestana, J. D.
    Vanrenterghem, Y.
    Vincenti, F.
    Florman, S.
    Block, A. J.
    Garg, P.
    Sen, K.
    Grinyo, J. M.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 89 - 89
  • [42] Primary Outcomes from a Randomized, Phase III Study of Belatacept vs Cyclosporine in ECD Kidney Transplants (BENEFIT-EXT Study).
    Durrbach, A.
    Larsen, C.
    Medina-Pestana, J. D.
    Vanrenterghem, Y.
    Vincenti, F.
    Florman, S.
    Block, A. J.
    Garg, P.
    Sen, K.
    Grinyo, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 199 - 199
  • [43] Three-Year Outcomes in Elderly Kidney Transplant Recipients Treated with Belatacept vs Cyclosporine in BENEFIT-EXT.
    Rice, K.
    Vanrenterghem, Y.
    Merville, P.
    Muehlbacher, F.
    Zhang, R.
    Duan, T.
    Thomas, D.
    Charpentier, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 403 - 403
  • [44] Belatacept Treated Patients Experience Improved Health-Related Quality of Life and Lower Symptom Distress Compared to Cyclosporine Treated Patients: An Analysis of the Benefit and Benefit-EXT Cohorts.
    Everly, M. J.
    Purnajo, I.
    Beaumont, J. L.
    Polinsky, M.
    Alemao, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 394 - 394
  • [45] COST EFFECTIVENESS OF BELATACEPT-VERSUS CYCLOSPORINE-TREATED RENAL TRANSPLANT PATIENTS USING RESULTS FROM THE BENEFIT STUDY
    Righetti, Carina
    Alemao, Evo
    Amadi, Adenike
    Mcewan, Phil
    Sugrue, Daniel
    TRANSPLANT INTERNATIONAL, 2015, 28 : 314 - 314
  • [46] Three-Year Outcomes in Patients with Delayed Graft Function in Phase III Studies of Belatacept Vs Cyclosporine in Kidney Transplantation (BENEFIT and BENEFIT-EXT)
    Charpentier, B.
    Vincenti, F.
    Rice, K.
    Budde, K.
    Campistol, J.
    Duan, T.
    Pupim, L.
    Florman, S.
    TRANSPLANTATION, 2012, 94 (10) : 996 - 996
  • [47] Outcomes at Five Years in Black/African-American Kidney Transplant Recipients from the Long-Term Extension of the Belatacept BENEFIT and BENEFIT-EXT Studies
    Florman, S.
    Rice, K.
    Chan, L.
    Zhang, R.
    Abouljoud, M.
    Steinberg, S.
    Pearson, T.
    Pupim, L.
    Vincenti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 311 - 311
  • [48] Four-Year Outcomes in Black/African American Kidney Transplant Recipients from the Long-Term Extension of the Belatacept BENEFIT and BENEFIT-EXT Studies.
    Florman, S.
    Rice, K.
    Chan, L.
    Steinberg, S.
    Pearson, T.
    Duan, T.
    Argawal, M.
    Vincenti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 404 - 404
  • [49] BELATACEPT PATIENTS HAD SUPERIOR GRAFT SURVIVAL COMPARED WITH CYCLOSPORINE PATIENTS: FINAL RESULTS FROM BENEFIT
    Vincenti, Flavio
    Grinyo, Josep
    Rostaing, Lionel
    Rice, Kim
    Steinberg, Steven
    Moal, Marie-Christine
    Polinsky, Marty
    Meier-Kriesche, Herwig-Ulf
    Larsen, Christian
    TRANSPLANT INTERNATIONAL, 2015, 28 : 81 - 81
  • [50] BELATACEPT PATIENTS HAD SUPERIOR GRAFT SURVIVAL COMPARED WITH CYCLOSPORINE PATIENTS: FINAL RESULTS FROM BENEFIT
    Vincenti, F.
    Bray, R.
    Gebel, H.
    Grinyo, J.
    Moal, M. -C.
    Rice, K.
    Rostaing, L.
    Steinberg, S.
    Meier-Kriesche, U.
    Polinsky, M.
    Townsend, R.
    Larsen, C. P.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 10 - 10
12345